Home
Farallon Capital Partners reported a 6.8% stake in Exelixis EXEL · 18,635,500 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 6.8%
- Last report
- 8.4% · filed 25/03/05
- Shares held
- 18,635,500 sh
- Class
- Common Stock, par value $0.001 per share (the "Shares")
- Stock
- Exelixis EXEL
- Event date
- 25/05/16
- Filed
- 25/05/20
6.8% stake · −1.6pp from the last report
- Stake
- 6.8%
- Last report
- 8.4%
- Since last report
- −1.6pp
Exelixis trades, last 26 weeks
What else happened in Exelixis around then
Filed or reported within 30 days of the trade day · 25/04/16~25/06/15Farallon Capital Partners's other 5% stake reports
- Farallon Capital Partners
5% stakeBridgeBio Pharma
5% stakeBridgeBio Pharma
BBIO
5.2% stake
10,226,063 sh
5.2% stake
Filed 05/29
- Farallon Capital Partners
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,500,000 sh
5.1% stake
Filed 05/14
- Farallon Capital Partners
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
6.6% stake
3,580,818 sh
6.6% stake
Filed 05/12
- Farallon Capital Partners
5% stakeBeta Bionics
5% stakeBeta Bionics
BBNX
8.1% stake
3,607,920 sh
8.1% stake
Filed 05/12
- Farallon Capital Partners
5% stakeGrail
5% stakeGrail
GRAL
7.8% stake
3,253,684 sh
7.8% stake
Filed 05/11
